Recent article by Pharmafocus discussing the impacts of Brexit on drug safety, including views from Sir Alasdair Breckenridge, former chair of the MHRA; Professor Saad Shakir, the Director of the Drug Safety Research Unit in Southampton; and myself.

Article version can be found here:

Pharmafocus - Drug Safety: UK and EU post-Brexit